In fiscal year 2020/21, ZEISS achieves highest revenue yet in its 175-year history at 7.5 billion euros (+20% compared to prior year) – including EBIT at 1.5 billion euros (+ 557 m euros as compared to prior year) All four ZEISS segments achieve double-digit revenue growth Significant investments in research and development pay off – [...]

Genedata Biologics integrates, automates, and streamlines Ligand Pharmaceuticals’ OmniAb in vivo antibody discovery platform Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Ligand Pharmaceuticals (NASDAQ: LGND) has chosen Genedata Biologics® as the global biologics R&D workflow and data management platform for their OmniAb antibody discovery platform. [...]

Merck today announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the first vaccine production facility in Nigeria. Supports West African pandemic readiness program Accelerates self-sufficient vaccine development and manufacturing in West Africa Merck, a leading science and technology company, today announced that it has [...]

MINNEAPOLIS and ST. PAUL, Minn. -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has entered into an option agreement with Wilson Wolf Corporation.   The agreement includes a potential 20% ownership investment in Wilson Wolf upon its achievement [...]

Marlborough, MA – Scitara Corporation, an innovator in laboratory digital transformation, has launched a ground-breaking advanced integration platform that creates a new industry category for the laboratory and scientific communities. The new Scitara Scientific Integration Platform™ (SIP™) presents a solution to the lab connectivity challenge that has dogged the industry for decades and, for the first time, allows [...]

The agreement with Thermo Fisher Scientific is providing life science researchers with comprehensive mass spectrometry solutions to gain deep proteomic insights at a large scale SCHLIEREN, (Zurich, Switzerland) – Biognosys, a leading developer and provider of next-generation proteomics technology and solutions, and Thermo Fisher Scientific, the world leader in serving science with innovative technologies, purchasing [...]

Purchase of key TetraScience Lab Monitoring business hardware, talent, and novel asset integrations creates a clear leader in the emerging field of LabOps. CAMBRIDGE, Mass. -- Elemental Machines, a manufacturer of universal laboratory asset management technology for research, clinical, and testing labs around the world, today announced its successful acquisition of the Tetra Lab Monitoring business from Boston-based [...]

MENLO PARK, Calif. and MADISON, Wis. -- Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, today announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and Jim Hagstrom in carrying the scientific legacy of the company forward with an expanded focus on enabling both the research and [...]

Creates a pure play Food Security company with pro forma revenue of approximately $1 billion and Adjusted EBITDA of approximately $300 million expected in its first full year post-closing. Pro forma company expected to have stronger growth through substantial cross synergies Combined company will have the enhanced geographic footprint, innovative product offerings, digitization capabilities, and [...]

Mr. Morales’ decades of financial experience in the life sciences sector will drive Vector Laboratories’ ongoing expansion strategy Burlingame, CA -- Vector Laboratories, the pioneer and leader in the development and manufacture of protein labeling and detection reagents for life sciences research, today announced that Mike Morales, CPA, has joined the Executive Team as Chief [...]